These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32663468)

  • 1. Clinical Trials in the Evolving Landscape of Precision Medicine.
    Cancer Cell; 2020 Jul; 38(1):3-8. PubMed ID: 32663468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
    Burstein HJ; Krilov L; Aragon-Ching JB; Baxter NN; Chiorean EG; Chow WA; De Groot JF; Devine SM; DuBois SG; El-Deiry WS; Epstein AS; Heymach J; Jones JA; Mayer DK; Miksad RA; Pennell NA; Sabel MS; Schilsky RL; Schuchter LM; Tung N; Winkfield KM; Wirth LJ; Dizon DS
    J Clin Oncol; 2017 Apr; 35(12):1341-1367. PubMed ID: 28148207
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspective on Precision Medicine in Oncology.
    Johnson TM
    Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.
    Smith SM; Wachter K; Burris HA; Schilsky RL; George DJ; Peterson DE; Johnson ML; Markham MJ; Mileham KF; Beg MS; Bendell JC; Dreicer R; Keedy VL; Kimple RJ; Knoll MA; LoConte N; MacKay H; Meisel JL; Moynihan TJ; Mulrooney DA; Mulvey TM; Odenike O; Pennell NA; Reeder-Hayes K; Smith C; Sullivan RJ; Uzzo R
    J Clin Oncol; 2021 Apr; 39(10):1165-1184. PubMed ID: 33527845
    [No Abstract]   [Full Text] [Related]  

  • 5. Future Approaches to Precision Oncology-Based Clinical Trials.
    Mittra A; Moscow JA
    Cancer J; 2019; 25(4):300-304. PubMed ID: 31335395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer genomics and clinical practice: how can we close the gap more quickly?
    Konecny GE
    Curr Opin Obstet Gynecol; 2017 Feb; 29(1):1-3. PubMed ID: 27941363
    [No Abstract]   [Full Text] [Related]  

  • 7. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of precision oncology basket and umbrella trials for clinicians.
    Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
    CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on 'preclinical and early-phase clinical pharmacology'.
    Leonetti A; Boyd L; Giuliani J; Giovannetti E; Garajová I
    Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1033-1036. PubMed ID: 31633383
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer research: Promise of protection.
    Chi KR
    Nature; 2011 Mar; 471(7339):537-8. PubMed ID: 21438188
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges and approaches to implementing master/basket trials in oncology.
    Burd A; Schilsky RL; Byrd JC; Levine RL; Papadimitrakopoulou VA; Herbst RS; Redman MW; Druker BJ; Gandara DR
    Blood Adv; 2019 Jul; 3(14):2237-2243. PubMed ID: 31337605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot studies for personalized cancer medicine: focusing on the patient for treatment selection.
    De Mattos-Arruda L; Rodon J
    Oncologist; 2013; 18(11):1180-8. PubMed ID: 24136009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. Introduction.
    Lin DW; Shore ND
    Urol Oncol; 2012; 30(4 Suppl):S1. PubMed ID: 22795074
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical cancer research: the past, present and the future.
    DeVita VT; Eggermont AM; Hellman S; Kerr DJ
    Nat Rev Clin Oncol; 2014 Nov; 11(11):663-9. PubMed ID: 25245981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-centric trials for therapeutic development in precision oncology.
    Biankin AV; Piantadosi S; Hollingsworth SJ
    Nature; 2015 Oct; 526(7573):361-70. PubMed ID: 26469047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology Developing First Clinical Trial.
    Brower V
    J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625
    [No Abstract]   [Full Text] [Related]  

  • 19. National Cancer Institute Basket/Umbrella Clinical Trials: MATCH, LungMAP, and Beyond.
    Chen AP; Eljanne M; Harris L; Malik S; Seibel NL
    Cancer J; 2019; 25(4):272-281. PubMed ID: 31335391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.
    Ersek JL; Black LJ; Thompson MA; Kim ES
    Am Soc Clin Oncol Educ Book; 2018 May; 38():188-196. PubMed ID: 30231363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.